Cargando…

Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study

BACKGROUND/AIMS: ONO-9054 is being developed for the reduction of intraocular pressure (IOP) in patients with ocular hypertension (OHT) and open-angle glaucoma (OAG). This study compared the novel dual EP3/FP agonist ONO-9054 with the FP agonist Xalatan. METHODS: Adults (n=123) with bilateral mild/m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miller Ellis, Eydie, Berlin, Michael S, Ward, Caroline L, Sharpe, John A, Jamil, Alam, Harris, Alon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583686/ https://www.ncbi.nlm.nih.gov/pubmed/27649982 http://dx.doi.org/10.1136/bjophthalmol-2016-309023

Ejemplares similares

EP3/FP dual receptor agonist ONO-9054 administered morning or evening to patients with open-angle glaucoma or ocular hypertension: results of a randomised crossover study
por: Berlin, Michael S, et al.
Publicado: (2016)

Utilidad terapéutica del latanoprost (xalatan) : revisión bibliográfica
por: Hernández Fernández, Felipe
Publicado: (1998)

The Roles Played by FP/EP3 Receptors During Pressure-lowering in Mouse Eyes Mediated by a Dual FP/EP3 Receptor Agonist
por: Yamagishi-Kimura, Reiko, et al.
Publicado: (2022)

Comparison of clinical effects of two latanoprost 0.005% solutions (Xalatan(®) and Arulatan(®)) in primary open-angle glaucoma or ocular hypertensive patients: a randomized clinical trial
por: Brant Fernandes, Rodrigo A, et al.
Publicado: (2019)

Screening of the Drug-Induced Effects of Prostaglandin EP2 and FP Agonists on 3D Cultures of Dexamethasone-Treated Human Trabecular Meshwork Cells
por: Watanabe, Megumi, et al.
Publicado: (2021)

Prostaglandin receptors EP and FP are regulated by estradiol and progesterone in the uterus of ovariectomized rats
por: Blesson, Chellakkan S, et al.
Publicado: (2012)

Effects of the Cathepsin K Inhibitor ONO-5334 and Concomitant Use of ONO-5334 with Methotrexate on Collagen-Induced Arthritis in Cynomolgus Monkeys
por: Yamada, Hiroyuki, et al.
Publicado: (2019)

Randomised clinical trial: exploratory phase 2 study of ONO‐2952 in diarrhoea‐predominant irritable bowel syndrome
por: Whitehead, W. E., et al.
Publicado: (2016)

Contribution of prostanoid FP receptor and prostaglandins in transient inflammatory ocular hypertension
por: Yamagishi-Kimura, Reiko, et al.
Publicado: (2018)

Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile
por: Pietra, Claudio, et al.
Publicado: (2014)

Synthesis and Applications of (ONO Pincer)Ruthenium‐Complex‐Bound Norvalines
por: Isozaki, Katsuhiro, et al.
Publicado: (2016)

Effect of ghrelin and anamorelin (ONO-7643), a selective ghrelin receptor agonist, on tumor growth in a lung cancer mouse xenograft model
por: Northrup, R., et al.
Publicado: (2013)

Innovative therapeutic strategy using prostaglandin I(2) agonist (ONO1301) combined with nano drug delivery system for pulmonary arterial hypertension
por: Kanaya, Tomomitsu, et al.
Publicado: (2021)

A novel prostaglandin I(2) agonist, ONO-1301, attenuates liver inflammation and suppresses fibrosis in non-alcoholic steatohepatitis model mice
por: Motegi, Satoko, et al.
Publicado: (2022)

Bruton tyrosine kinase inhibitor ONO/GS-4059: from bench to bedside
por: Wu, Jingjing, et al.
Publicado: (2016)

A 4-week, dose-ranging study comparing the efficacy, safety and tolerability of latanoprost 75, 100 and 125 μg/mL to latanoprost 50 μg/mL (xalatan) in the treatment of primary open-angle glaucoma and ocular hypertension
por: Eveleth, David, et al.
Publicado: (2012)

MON-477 Octreotide and ONO-ST-468, a Novel and Potent Somatostatin Receptor Type-2 (SST2) Agonist, Suppress GH Hypersecretion in the Monkey
por: Tanaka, Hirotaka, et al.
Publicado: (2019)

Morning vs evening dosing of the cathepsin K inhibitor ONO-5334: effects on bone resorption in postmenopausal women in a randomized, phase 1 trial
por: Eastell, R., et al.
Publicado: (2015)

Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexes
por: Liang, Y, et al.
Publicado: (2008)

Genetics, structure, and prevalence of FP967 (CDC Triffid) T-DNA in flax
por: Young, Lester, et al.
Publicado: (2015)

Fabrication of a double-sided silicon microstrip detector with an ONO capacitor dielectric film
por: Saitô, Y, et al.
Publicado: (1995)

ONO-AE3-208 inhibits myeloid derived suppressor cells and glioma growth
por: Kohanbash, Gary, et al.
Publicado: (2014)

Pharmacokinetics and safety/efficacy of levodopa pro-drug ONO-2160/carbidopa for Parkinson's disease
por: Nomoto, Masahiro, et al.
Publicado: (2018)

Bimetallic iron–iron and iron–zinc complexes of the redox-active ONO pincer ligand
por: Wong, Janice L., et al.
Publicado: (2016)

Anamorelin (ONO‐7643) for the treatment of patients with non–small cell lung cancer and cachexia: Results from a randomized, double‐blind, placebo‐controlled, multicenter study of Japanese patients (ONO‐7643‐04)
por: Katakami, Nobuyuki, et al.
Publicado: (2017)

CD28, Costimulator or Agonist Receptor?
por: Margulies, David H.
Publicado: (2003)

A sustained-release drug-delivery system of synthetic prostacyclin agonist, ONO-1301SR: a new reagent to enhance cardiac tissue salvage and/or regeneration in the damaged heart
por: Fukushima, Satsuki, et al.
Publicado: (2015)

MON-464 Non-Clinical Profiling of ONO-5788, a Novel Oral Small Molecule Somatostatin Receptor Type-2 (SST2) Agonist, to Support Studies in Humans
por: Komagata, Tatsuya, et al.
Publicado: (2019)

Correction: Ono, K. Calibration Methods of Acoustic Emission Sensors. Materials 2016, 9, 508
por: Ono, Kanji
Publicado: (2016)

Prophylactic ocular hypotensives before Nd:YAG laser posterior capsulotomy
por: Dubey, Ashok K.
Publicado: (2012)

EP2 receptor mediated cAMP release is augmented by PGF(2α) activation of the FP receptor via the calcium-calmodulin pathway
por: Abera, A.B., et al.
Publicado: (2010)

Three‐year follow‐up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non‐small cell lung cancer: Pooled analysis of ONO‐4538‐05 and ONO‐4538‐06 studies
por: Horinouchi, Hidehito, et al.
Publicado: (2019)

Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studies
por: Saka, Hideo, et al.
Publicado: (2020)

Effect of cerebrospinal fluid area mask correction on (123)I-FP-CIT SPECT images in idiopathic normal pressure hydrocephalus
por: Ohba, Makoto, et al.
Publicado: (2023)

EP28 A case of ANCA vasculitis presenting with Sjögren’s serology
por: Ayub, Shazeen, et al.
Publicado: (2020)

FP/FORM Versus FP/SAL Within Clinical Practice: An Updated Budget Impact Analysis in Asthma
por: Farrington, Emily, et al.
Publicado: (2016)

16 FP : cuestionario de 16 factores de la personalidad : manual /
Publicado: (2001)

Homogeneous BTK Occupancy Assay for Pharmacodynamic Assessment of Tirabrutinib (GS-4059/ONO-4059) Target Engagement
por: Yu, Helen, et al.
Publicado: (2018)

Germanium Complexes with ONO Tridentate Ligands: O-H Bond Activation Control According to DFT Calculations
por: Zaitsev, Kirill V., et al.
Publicado: (2023)

Face Mask-Associated Ocular Irritation and Dryness
por: Moshirfar, Majid, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4rssirol31cqo61iar5nn0kg3f